William Rice

Verkställande Direktör på APTOSE BIOSCIENCES INC.

Förmögenhet: 10 131 $ per 2026-05-31

67 år

69 relationer

Health Technology

Consumer Services

Electronic Technology

Profil

William G.
Rice was the founder of Achillion Pharmaceuticals, Inc., founded in 1998, where the titles held included President, Chief Executive Officer & Director from 1998 to 2003.
Current jobs include Chairman, President & Chief Executive Officer at Aptose Biosciences, Inc. since 2013, and Chairman at Cylene Pharmaceuticals, Inc. since 2013, with employment starting in 2003.
Former jobs include Independent Director at Oncolytics Biotech, Inc. from 2015 to 2021, Member-Pediatric Hematology & Oncology at Emory University School of Medicine from 1989 to 1992, and Senior Scientist & Head-Drug Mechanism Lab at Frederick National Laboratory For Cancer Research from 1992 to 1998.
Education includes a doctorate degree from Emory University, conferred in 1986.

Kända innehav i offentliga företag

Företag	Datum	Antal aktier	Värdering	Värderingsdatum
APTOSE BIOSCIENCES INC. 0,24 %	2026-02-23	6 140 ( 0,24 % )	10 131 $	2026-05-31

Aktiva positioner av William Rice

Företag	Position	Start
APTOSE BIOSCIENCES INC.	Verkställande Direktör	2013-10-28
Cylene Pharmaceuticals, Inc. Cylene Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes small molecule drugs	Ordförande	2010-09-28

Alla aktiva positioner av William Rice

Tidigare kända positioner av William Rice

Företag	Position	Slut
ONCOLYTICS BIOTECH INC.	Direktör/Styrelseledamot	2021-01-01
ACHILLION PHARMACEUTICALS, INC.	Grundare	2003-08-01
Frederick National Laboratory For Cancer Research Frederick National Laboratory For Cancer Research Aerospace & DefenseElectronic Technology The Frederick National Laboratory for Cancer Research (FNLCR), operated by Leidos Biomedical Research, Inc. for the National Cancer Institute, is a government-affiliated biomedical research institution dedicated to advancing cancer, AIDS, and infectious disease research. The company is based in Frederick and ultimately controlled by the Government of the United States of America. It offers scientific programs, specialized laboratories, and technological platforms such as cryo-electron microscopy, nanotechnology characterization, molecular diagnostics, protein expression, and laboratory animal sciences. FNLCR develops scientific standards and reference materials to enhance research quality and data reliability, and its initiatives include the RAS Initiative targeting cancer-driving genes, vaccine development programs, precision medicine trials for blood cancers, and viral oncology research. The laboratory supports investigators with scientific expertise, technical services, user facilities, and training modules, and fosters collaboration across government, academia, and industry through technology transfer, licensing, and partnerships. FNLCR also engages in community outreach, workforce development, and diversity initiatives.	Företagsledare/Principal	1998-01-01
Emory University School of Medicine Emory University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University	Företagsledare/Principal	1992-01-01

Se detaljerna i William Rices erfarenhet

William Rices utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Se detaljerna i William Rices erfarenhet

Relationer

Första gradens relationer

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Se det personliga nätverket

Kopplade företag

Privata företag	7
Aptose Biosciences, Inc. Aptose Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Discovers, research and develops anticancer therapies with high safety profiles	Health Technology
Oncolytics Biotech, Inc. Oncolytics Biotech, Inc. BiotechnologyHealth Technology Discovers and develops pharmaceutical products for the treatment of cancers	Health Technology
Cylene Pharmaceuticals, Inc. Cylene Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes small molecule drugs	Health Technology
Achillion Pharmaceuticals, Inc. Achillion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes treatments for infectious diseases	Health Technology
Emory University Emory University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Emory University School of Medicine Emory University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Frederick National Laboratory For Cancer Research Frederick National Laboratory For Cancer Research Aerospace & DefenseElectronic Technology The Frederick National Laboratory for Cancer Research (FNLCR), operated by Leidos Biomedical Research, Inc. for the National Cancer Institute, is a government-affiliated biomedical research institution dedicated to advancing cancer, AIDS, and infectious disease research. The company is based in Frederick and ultimately controlled by the Government of the United States of America. It offers scientific programs, specialized laboratories, and technological platforms such as cryo-electron microscopy, nanotechnology characterization, molecular diagnostics, protein expression, and laboratory animal sciences. FNLCR develops scientific standards and reference materials to enhance research quality and data reliability, and its initiatives include the RAS Initiative targeting cancer-driving genes, vaccine development programs, precision medicine trials for blood cancers, and viral oncology research. The laboratory supports investigators with scientific expertise, technical services, user facilities, and training modules, and fosters collaboration across government, academia, and industry through technology transfer, licensing, and partnerships. FNLCR also engages in community outreach, workforce development, and diversity initiatives.	Electronic Technology